Skip to main navigation Skip to search Skip to main content

Switching to insulin lispro U-200 in a pregnant woman using a 780G advanced hybrid closed-loop led to a rapid improvement in glucose metrics

  • Lilian C. Mendoza
  • , Ohad Cohen
  • , Vittorino Smaniotto
  • , Rosa Corcoy*
  • *Corresponding author for this work
  • Hospital de La Santa Creu I Sant Pau
  • Centro de Investigación Biomédica en Red
  • Autonomous University of Barcelona
  • Medtronic Europe

Research output: Contribution to journalArticlepeer-review

Abstract

Maintaining tight glucose levels during pregnancy is crucial and challenging. We describe a pregnant woman with type 1 diabetes and obesity, treated with an advanced hybrid closed-loop MiniMed 780G since pre-pregnancy, who displayed a sustained improvement in her glucometrics after switching to lispro U-200.

Original languageEnglish
Article number112047
JournalDiabetes Research and Clinical Practice
Volume222
DOIs
StatePublished - Apr 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hybrid closed-loop
  • Insulin U-200
  • Pregnancy
  • Type 1 diabetes

Fingerprint

Dive into the research topics of 'Switching to insulin lispro U-200 in a pregnant woman using a 780G advanced hybrid closed-loop led to a rapid improvement in glucose metrics'. Together they form a unique fingerprint.

Cite this